This website uses cookies. By continuing you are agreeing to our privacy policy.

David Hall, M.D.

Research Awards Nationwide Recipient (2017-2018)

University of Florida
Increasing the Number of Suitable Donor Lungs for Transplantation
Senior Research Training Fellowship

Currently, only 22 percent of lungs from multi-organ donors are used for transplantation; the majority of potential donor lungs are rejected due to poor function. A novel technique called ex vivo lung perfusion (EVLP) has been shown to improve marginal donor lungs to the level of standard-criteria lungs. Using deceased donor pig lungs, we will study a medication that blocks endothelin-1 (ET-1), which constricts blood vessels in the lungs. Previous studies have found ET-1 blockers reduce donor lung injury. If found safe and effective in these preclinical models, the ultimate goal will be a clinical trial that blocks ET-1 to improve and rehabilitate human lungs prior to transplantation, allowing potential expansion of the donor pool.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.


Breathe Easy

Give today and your tax-deductible gift will go TWICE as far for everyone who struggles to breathe.